InvestorsHub Logo
Followers 209
Posts 32165
Boards Moderated 1
Alias Born 06/30/2009

Re: None

Sunday, 10/16/2022 7:28:54 AM

Sunday, October 16, 2022 7:28:54 AM

Post# of 403079
Is a Research publication reliable when it tells you in 2018 that....
“In 2017, the global antifungal drugs market size was valued at USD 11.3 billion. Growing prevalence of fungal infections such as aspergillosis and candidiasis is one of the key factors propelling the market.”
.....and that the the global antifungal drugs market size is expected to reach USD 12.7 billion by 2025, progressing at a CAGR of 1.5% during the forecast period."

And then in 2022 tells you that....
"The global antifungal drugs market size was valued at USD 14.8 billion in 2021" and that "The global antifungal drugs market size is expected to reach USD 20.5 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 3.7% from 2022 to 2030."
...in a press release linked and a statistic referenced by IPIX in ITS latest press release?

The same "research" company that reported that the global antifungal drugs market size was expected to reach USD 12.7 billion by 2025 subsequently proceeded to state that the global antifungal drugs market size was already valued at USD 14.8 billion in 2021.

Is this "research" really designed to inform investors? It sure does seem like a handy tool for CEO's to employ in the process of promoting their companies.

“I have had a wonderful time but this wasn't it.”
..........Groucho

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News